RIYADH — The Ministry of Investment of Saudi Arabia (MISA) and British pharmaceutical company GlaxoSmithKline Consumer HealthCare (GSK) have announced that they have signed an agreement to support the development of the medical self-care sector in the Kingdom.

As part of the agreement, MISA and GSK have agreed to work together to localize manufacturing, transfer knowledge and technology, and establish the Kingdom as a hub for research in the medical self-care industry.

Supporting the development of the self-care sector is expected to reduce overall healthcare costs by enabling people to tend more effectively to minor ailments themselves. — SPA